168 related articles for article (PubMed ID: 31343784)
1. MYCN gene polymorphisms and Wilms tumor susceptibility in Chinese children.
Huang X; Zhao J; Zhu J; Chen S; Fu W; Tian X; Lou S; Ruan J; He J; Zhou H
J Clin Lab Anal; 2019 Nov; 33(9):e22988. PubMed ID: 31343784
[TBL] [Abstract][Full Text] [Related]
2. ALKBH5 gene polymorphisms and Wilms tumor risk in Chinese children: A five-center case-control study.
Hua RX; Liu J; Fu W; Zhu J; Zhang J; Cheng J; Li S; Zhou H; Xia H; He J; Zhuo Z
J Clin Lab Anal; 2020 Jun; 34(6):e23251. PubMed ID: 32091154
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in
Zhou H; Zhuo Z; Chen S; Zhao J; Mo Y; Zhang J; He J; Ruan J
Cancer Manag Res; 2018; 10():1807-1816. PubMed ID: 29997440
[TBL] [Abstract][Full Text] [Related]
4. YTHDC1 gene polymorphisms and Wilms tumor susceptibility in Chinese children: A five-center case-control study.
Lin A; Hua RX; Zhou M; Fu W; Zhang J; Zhou H; Li S; Cheng J; Zhu J; Xia H; Liu G; He J
Gene; 2021 May; 783():145571. PubMed ID: 33737126
[TBL] [Abstract][Full Text] [Related]
5. Role of FTO gene polymorphisms in Wilms tumor predisposition: A five-center case-control study.
Hua RX; Fu W; Lin A; Zhou H; Cheng J; Zhang J; Li S; Liu G; Xia H; Zhuo Z; He J
J Gene Med; 2021 Aug; 23(8):e3348. PubMed ID: 33894035
[TBL] [Abstract][Full Text] [Related]
6. H19 gene polymorphisms and Wilms tumor risk in Chinese children: a four-center case-control study.
Li W; Hua RX; Wang M; Zhang D; Zhu J; Zhang S; Yang Y; Cheng J; Zhou H; Zhang J; He J
Mol Genet Genomic Med; 2021 Feb; 9(2):e1584. PubMed ID: 33403826
[TBL] [Abstract][Full Text] [Related]
7. METTL3 polymorphisms and Wilms tumor susceptibility in Chinese children: A five-center case-control study.
Lin A; Zhou M; Hua RX; Zhang J; Zhou H; Li S; Cheng J; Xia H; Fu W; He J
J Gene Med; 2020 Nov; 22(11):e3255. PubMed ID: 32716082
[TBL] [Abstract][Full Text] [Related]
8. The contribution of WTAP gene variants to Wilms tumor susceptibility.
Ma L; Hua RX; Lin H; Zhu J; Fu W; Lin A; Zhang J; Cheng J; Zhou H; Li S; Zhuo Z; He J
Gene; 2020 Sep; 754():144839. PubMed ID: 32504654
[TBL] [Abstract][Full Text] [Related]
9. Impact of YTHDF1 gene polymorphisms on Wilms tumor susceptibility: A five-center case-control study.
Liu Y; Lin H; Hua RX; Zhang J; Cheng J; Li S; Zhou H; Zhuo Z; Bian J
J Clin Lab Anal; 2021 Aug; 35(8):e23875. PubMed ID: 34151473
[TBL] [Abstract][Full Text] [Related]
10. The correlation between LIN28B gene potentially functional variants and Wilms tumor susceptibility in Chinese children.
Fu W; Liu GC; Zhao Z; Zhu J; Jia W; Zhu SB; Hu JH; Wang FH; He J; Xia H
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28301057
[TBL] [Abstract][Full Text] [Related]
11. Association Between HACE1 Gene Polymorphisms and Wilms' Tumor Risk in a Chinese Population.
Jia W; Deng Z; Zhu J; Fu W; Zhu S; Zhang LY; Hu J; Wang F; Xia H; Liu GC; He J
Cancer Invest; 2017 Nov; 35(10):633-638. PubMed ID: 29243987
[TBL] [Abstract][Full Text] [Related]
12. HMGA2 gene polymorphisms and Wilms tumor susceptibility in Chinese children: a four-center case-control study.
Cheng J; Zhuo Z; Yang L; Zhao P; Zhang J; Zhou H; He J; Li P
Biotechnol Appl Biochem; 2020 Nov; 67(6):939-945. PubMed ID: 31746066
[TBL] [Abstract][Full Text] [Related]
13. The association of miR34b/c and TP53 gene polymorphisms with Wilms tumor risk in Chinese children.
Wang J; Lou S; Huang X; Mo Y; Wang Z; Zhu J; Tian X; Shi J; Zhou H; He J; Ruan J
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32083300
[TBL] [Abstract][Full Text] [Related]
14. Constitutional 560.49 kb chromosome 2p24.3 duplication including the MYCN gene identified by SNP chromosome microarray analysis in a child with multiple congenital anomalies and bilateral Wilms tumor.
Micale MA; Embrey B; Macknis JK; Harper CE; Aughton DJ
Eur J Med Genet; 2016 Dec; 59(12):618-623. PubMed ID: 27794475
[TBL] [Abstract][Full Text] [Related]
15. METTL14 gene polymorphisms decrease Wilms tumor susceptibility in Chinese children.
Zhuo Z; Hua RX; Zhang H; Lin H; Fu W; Zhu J; Cheng J; Zhang J; Li S; Zhou H; Xia H; Liu G; Jia W; He J
BMC Cancer; 2021 Dec; 21(1):1294. PubMed ID: 34863142
[TBL] [Abstract][Full Text] [Related]
16. Association of
Fu W; Zhuo Z; Hua RX; Fu K; Jia W; Zhu J; Zhang J; Cheng J; Zhou H; Xia H; He J; Liu G
Aging (Albany NY); 2019 Mar; 11(5):1551-1563. PubMed ID: 30860980
[TBL] [Abstract][Full Text] [Related]
17. Association between PHOX2B gene rs28647582 T>C polymorphism and Wilms tumor susceptibility.
Lin A; Fu W; Wang W; Zhu J; Liu J; Xia H; Liu G; He J
Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31652452
[TBL] [Abstract][Full Text] [Related]
18. Bromodomain 4 inhibition leads to MYCN downregulation in Wilms tumor.
Woods AD; Berlow NE; Ortiz MV; Dela Cruz F; Siddiquee A; Coutinho DF; Purohit R; Freier KET; Michalek JE; Lathara M; Matlock K; Srivivasa G; Royer-Pokora B; Veselska R; Kung AL; Keller C
Pediatr Blood Cancer; 2022 Feb; 69(2):e29401. PubMed ID: 34693628
[TBL] [Abstract][Full Text] [Related]
19. Multiple mechanisms of MYCN dysregulation in Wilms tumour.
Williams RD; Chagtai T; Alcaide-German M; Apps J; Wegert J; Popov S; Vujanic G; van Tinteren H; van den Heuvel-Eibrink MM; Kool M; de Kraker J; Gisselsson D; Graf N; Gessler M; Pritchard-Jones K
Oncotarget; 2015 Mar; 6(9):7232-43. PubMed ID: 25749049
[TBL] [Abstract][Full Text] [Related]
20.
Liu J; Hua RX; Fu W; Zhu J; Jia W; Zhang J; Zhou H; Cheng J; Xia H; Liu G; He J
Ann Transl Med; 2019 Sep; 7(18):475. PubMed ID: 31700911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
